Cargando…
Cathepsin K induces platelet dysfunction and affects cell signaling in breast cancer - molecularly distinct behavior of cathepsin K in breast cancer
BACKGROUND: Breast cancer comprises clinically and molecularly distinct tumor subgroups that differ in cell histology and biology and show divergent clinical phenotypes that impede phase III trials, such as those utilizing cathepsin K inhibitors. Here we correlate the epithelial-mesenchymal-like tra...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4774035/ https://www.ncbi.nlm.nih.gov/pubmed/26931461 http://dx.doi.org/10.1186/s12885-016-2203-7 |
_version_ | 1782418844684386304 |
---|---|
author | Andrade, Sheila Siqueira Gouvea, Iuri Estrada Silva, Mariana Cristina C. Castro, Eloísa Dognani de Paula, Cláudia A. A. Okamoto, Debora Oliveira, Lilian Peres, Giovani Bravin Ottaiano, Tatiana Facina, Gil Nazário, Afonso Celso Pinto Campos, Antonio Hugo J. F. M. Paredes-Gamero, Edgar Julian Juliano, Maria da Silva, Ismael D. C. G. Oliva, Maria Luiza V. Girão, Manoel J. B. C. |
author_facet | Andrade, Sheila Siqueira Gouvea, Iuri Estrada Silva, Mariana Cristina C. Castro, Eloísa Dognani de Paula, Cláudia A. A. Okamoto, Debora Oliveira, Lilian Peres, Giovani Bravin Ottaiano, Tatiana Facina, Gil Nazário, Afonso Celso Pinto Campos, Antonio Hugo J. F. M. Paredes-Gamero, Edgar Julian Juliano, Maria da Silva, Ismael D. C. G. Oliva, Maria Luiza V. Girão, Manoel J. B. C. |
author_sort | Andrade, Sheila Siqueira |
collection | PubMed |
description | BACKGROUND: Breast cancer comprises clinically and molecularly distinct tumor subgroups that differ in cell histology and biology and show divergent clinical phenotypes that impede phase III trials, such as those utilizing cathepsin K inhibitors. Here we correlate the epithelial-mesenchymal-like transition breast cancer cells and cathepsin K secretion with activation and aggregation of platelets. Cathepsin K is up-regulated in cancer cells that proteolyze extracellular matrix and contributes to invasiveness. Although proteolytically activated receptors (PARs) are activated by proteases, the direct interaction of cysteine cathepsins with PARs is poorly understood. In human platelets, PAR-1 and −4 are highly expressed, but PAR-3 shows low expression and unclear functions. METHODS: Platelet aggregation was monitored by measuring changes in turbidity. Platelets were immunoblotted with anti-phospho and total p38, Src-Tyr-416, FAK-Tyr-397, and TGFβ monoclonal antibody. Activation was measured in a flow cytometer and calcium mobilization in a confocal microscope. Mammary epithelial cells were prepared from the primary breast cancer samples of 15 women with Luminal-B subtype to produce primary cells. RESULTS: We demonstrate that platelets are aggregated by cathepsin K in a dose-dependent manner, but not by other cysteine cathepsins. PARs-3 and −4 were confirmed as the cathepsin K target by immunodetection and specific antagonists using a fibroblast cell line derived from PARs deficient mice. Moreover, through co-culture experiments, we show that platelets activated by cathepsin K mediated the up-regulation of SHH, PTHrP, OPN, and TGFβ in epithelial-mesenchymal-like cells from patients with Luminal B breast cancer. CONCLUSIONS: Cathepsin K induces platelet dysfunction and affects signaling in breast cancer cells. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-016-2203-7) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4774035 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-47740352016-03-03 Cathepsin K induces platelet dysfunction and affects cell signaling in breast cancer - molecularly distinct behavior of cathepsin K in breast cancer Andrade, Sheila Siqueira Gouvea, Iuri Estrada Silva, Mariana Cristina C. Castro, Eloísa Dognani de Paula, Cláudia A. A. Okamoto, Debora Oliveira, Lilian Peres, Giovani Bravin Ottaiano, Tatiana Facina, Gil Nazário, Afonso Celso Pinto Campos, Antonio Hugo J. F. M. Paredes-Gamero, Edgar Julian Juliano, Maria da Silva, Ismael D. C. G. Oliva, Maria Luiza V. Girão, Manoel J. B. C. BMC Cancer Research Article BACKGROUND: Breast cancer comprises clinically and molecularly distinct tumor subgroups that differ in cell histology and biology and show divergent clinical phenotypes that impede phase III trials, such as those utilizing cathepsin K inhibitors. Here we correlate the epithelial-mesenchymal-like transition breast cancer cells and cathepsin K secretion with activation and aggregation of platelets. Cathepsin K is up-regulated in cancer cells that proteolyze extracellular matrix and contributes to invasiveness. Although proteolytically activated receptors (PARs) are activated by proteases, the direct interaction of cysteine cathepsins with PARs is poorly understood. In human platelets, PAR-1 and −4 are highly expressed, but PAR-3 shows low expression and unclear functions. METHODS: Platelet aggregation was monitored by measuring changes in turbidity. Platelets were immunoblotted with anti-phospho and total p38, Src-Tyr-416, FAK-Tyr-397, and TGFβ monoclonal antibody. Activation was measured in a flow cytometer and calcium mobilization in a confocal microscope. Mammary epithelial cells were prepared from the primary breast cancer samples of 15 women with Luminal-B subtype to produce primary cells. RESULTS: We demonstrate that platelets are aggregated by cathepsin K in a dose-dependent manner, but not by other cysteine cathepsins. PARs-3 and −4 were confirmed as the cathepsin K target by immunodetection and specific antagonists using a fibroblast cell line derived from PARs deficient mice. Moreover, through co-culture experiments, we show that platelets activated by cathepsin K mediated the up-regulation of SHH, PTHrP, OPN, and TGFβ in epithelial-mesenchymal-like cells from patients with Luminal B breast cancer. CONCLUSIONS: Cathepsin K induces platelet dysfunction and affects signaling in breast cancer cells. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-016-2203-7) contains supplementary material, which is available to authorized users. BioMed Central 2016-03-01 /pmc/articles/PMC4774035/ /pubmed/26931461 http://dx.doi.org/10.1186/s12885-016-2203-7 Text en © Andrade et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Andrade, Sheila Siqueira Gouvea, Iuri Estrada Silva, Mariana Cristina C. Castro, Eloísa Dognani de Paula, Cláudia A. A. Okamoto, Debora Oliveira, Lilian Peres, Giovani Bravin Ottaiano, Tatiana Facina, Gil Nazário, Afonso Celso Pinto Campos, Antonio Hugo J. F. M. Paredes-Gamero, Edgar Julian Juliano, Maria da Silva, Ismael D. C. G. Oliva, Maria Luiza V. Girão, Manoel J. B. C. Cathepsin K induces platelet dysfunction and affects cell signaling in breast cancer - molecularly distinct behavior of cathepsin K in breast cancer |
title | Cathepsin K induces platelet dysfunction and affects cell signaling in breast cancer - molecularly distinct behavior of cathepsin K in breast cancer |
title_full | Cathepsin K induces platelet dysfunction and affects cell signaling in breast cancer - molecularly distinct behavior of cathepsin K in breast cancer |
title_fullStr | Cathepsin K induces platelet dysfunction and affects cell signaling in breast cancer - molecularly distinct behavior of cathepsin K in breast cancer |
title_full_unstemmed | Cathepsin K induces platelet dysfunction and affects cell signaling in breast cancer - molecularly distinct behavior of cathepsin K in breast cancer |
title_short | Cathepsin K induces platelet dysfunction and affects cell signaling in breast cancer - molecularly distinct behavior of cathepsin K in breast cancer |
title_sort | cathepsin k induces platelet dysfunction and affects cell signaling in breast cancer - molecularly distinct behavior of cathepsin k in breast cancer |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4774035/ https://www.ncbi.nlm.nih.gov/pubmed/26931461 http://dx.doi.org/10.1186/s12885-016-2203-7 |
work_keys_str_mv | AT andradesheilasiqueira cathepsinkinducesplateletdysfunctionandaffectscellsignalinginbreastcancermolecularlydistinctbehaviorofcathepsinkinbreastcancer AT gouveaiuriestrada cathepsinkinducesplateletdysfunctionandaffectscellsignalinginbreastcancermolecularlydistinctbehaviorofcathepsinkinbreastcancer AT silvamarianacristinac cathepsinkinducesplateletdysfunctionandaffectscellsignalinginbreastcancermolecularlydistinctbehaviorofcathepsinkinbreastcancer AT castroeloisadognani cathepsinkinducesplateletdysfunctionandaffectscellsignalinginbreastcancermolecularlydistinctbehaviorofcathepsinkinbreastcancer AT depaulaclaudiaaa cathepsinkinducesplateletdysfunctionandaffectscellsignalinginbreastcancermolecularlydistinctbehaviorofcathepsinkinbreastcancer AT okamotodebora cathepsinkinducesplateletdysfunctionandaffectscellsignalinginbreastcancermolecularlydistinctbehaviorofcathepsinkinbreastcancer AT oliveiralilian cathepsinkinducesplateletdysfunctionandaffectscellsignalinginbreastcancermolecularlydistinctbehaviorofcathepsinkinbreastcancer AT peresgiovanibravin cathepsinkinducesplateletdysfunctionandaffectscellsignalinginbreastcancermolecularlydistinctbehaviorofcathepsinkinbreastcancer AT ottaianotatiana cathepsinkinducesplateletdysfunctionandaffectscellsignalinginbreastcancermolecularlydistinctbehaviorofcathepsinkinbreastcancer AT facinagil cathepsinkinducesplateletdysfunctionandaffectscellsignalinginbreastcancermolecularlydistinctbehaviorofcathepsinkinbreastcancer AT nazarioafonsocelsopinto cathepsinkinducesplateletdysfunctionandaffectscellsignalinginbreastcancermolecularlydistinctbehaviorofcathepsinkinbreastcancer AT camposantoniohugojfm cathepsinkinducesplateletdysfunctionandaffectscellsignalinginbreastcancermolecularlydistinctbehaviorofcathepsinkinbreastcancer AT paredesgameroedgarjulian cathepsinkinducesplateletdysfunctionandaffectscellsignalinginbreastcancermolecularlydistinctbehaviorofcathepsinkinbreastcancer AT julianomaria cathepsinkinducesplateletdysfunctionandaffectscellsignalinginbreastcancermolecularlydistinctbehaviorofcathepsinkinbreastcancer AT dasilvaismaeldcg cathepsinkinducesplateletdysfunctionandaffectscellsignalinginbreastcancermolecularlydistinctbehaviorofcathepsinkinbreastcancer AT olivamarialuizav cathepsinkinducesplateletdysfunctionandaffectscellsignalinginbreastcancermolecularlydistinctbehaviorofcathepsinkinbreastcancer AT giraomanoeljbc cathepsinkinducesplateletdysfunctionandaffectscellsignalinginbreastcancermolecularlydistinctbehaviorofcathepsinkinbreastcancer |